While protein expression analysis revealed a significant decrease in P53, Bcl2, ß-actin, and GAPDH in the MA1-treated ovarian cancer cells, caspase3 and caspase 9 protein expression status did not change significantly. This evidence concerns the gene BCL2 and ovarian carcinoma.